Status:
COMPLETED
A Study Of Intravenous Sulopenem And Oral PF-03709270 In Community Acquired Pneumonia That Requires Hospitalization
Lead Sponsor:
Pfizer
Conditions:
Pneumonia, Bacterial
Eligibility:
All Genders
18+ years
Phase:
PHASE2
Brief Summary
The purpose of this study is to test if intravenous sulopenem and an oral drug, PF-03709270 are safe and effective in patients that are hospitalized with community acquired pneumonia.
Eligibility Criteria
Inclusion
- Hospitalized male or female patients 18 years of age or older.
- Female patients of childbearing potential must not be pregnant.
- Must exhibit at least two pre-specified clinical symptoms/signs of pneumonia.
- Must require hospitalization for the pneumonia.
- Chest Xray must be suggestive of a pneumonia.
Exclusion
- Hospital or ventilator associated pneumonia.
- Patients with cystic fibrosis, pneumocystis carinii pneumonia or active tuberculosis.
- Previous treatment for the current pneumonia episode received for more than 24 hours.
- Allergies to penems or beta lactams.
Key Trial Info
Start Date :
January 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2009
Estimated Enrollment :
35 Patients enrolled
Trial Details
Trial ID
NCT00797108
Start Date
January 1 2009
End Date
June 1 2009
Last Update
March 10 2016
Active Locations (24)
Enter a location and click search to find clinical trials sorted by distance.
1
eStudySite, Inc.
Chula Vista, California, United States, 91911
2
Sharp Chula Vista Medical Center
Chula Vista, California, United States, 91911
3
eStudySite, Inc.
Oceanside, California, United States, 92056
4
Tri-City Medical Center
Oceanside, California, United States, 92056